What drugs target IMPDH type II?

7+ drugs target IMPDH type II, including Mycophénolate Mofétil, Mycophenolate Na, Mycophenolate Mofetil (MMF), Mycophenolate mofetil, Standard dose, Myfortic Escalation.

What drug classes act on IMPDH type II?

Drug classes acting on IMPDH type II include Inosine monophosphate dehydrogenase (IMPDH) inhibitor.

IMPDH type II — Drug Target

7 drugs 6 marketed 1 in Phase 3

All drugs that target IMPDH type II — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Inosine monophosphate dehydrogenase (IMPDH) inhibitor

Marketed (6)

Mycophénolate Mofétil · University Hospital, Limoges · Inosine monophosphate dehydrogenase (IMPDH) inhibitor · Immunology
Mycophenolate mofetil inhibits inosine monophosphate dehydrogenase (IMPDH), selectively suppressing T and B lymphocyte proliferation to prevent immune rejection.
Mycophenolate Na · Sanofi · Inosine monophosphate dehydrogenase (IMPDH) inhibitor · Immunology
Mycophenolate sodium inhibits inosine monophosphate dehydrogenase (IMPDH), selectively suppressing T and B lymphocyte proliferation to prevent organ rejection.
Mycophenolate Mofetil (MMF) · ITB-Med LLC · Inosine monophosphate dehydrogenase (IMPDH) inhibitor · Immunology
Mycophenolate mofetil is a prodrug that inhibits inosine monophosphate dehydrogenase (IMPDH), selectively suppressing T and B lymphocyte proliferation to prevent organ rejection and treat autoimmune diseases.
Mycophenolate mofetil, Standard dose · Hoffmann-La Roche · Inosine monophosphate dehydrogenase (IMPDH) inhibitor · Immunology
Mycophenolate mofetil inhibits inosine monophosphate dehydrogenase (IMPDH), selectively suppressing T and B lymphocyte proliferation to prevent organ rejection and autoimmune responses.
Myfortic Escalation · East Carolina University · Inosine monophosphate dehydrogenase (IMPDH) inhibitor · Immunology
Myfortic (mycophenolate sodium) is an inosine monophosphate dehydrogenase (IMPDH) inhibitor that suppresses T and B lymphocyte proliferation to prevent organ rejection.
Mycophenolate Mofeti · National Cancer Institute (NCI) · Inosine monophosphate dehydrogenase (IMPDH) inhibitor · Immunology
Mycophenolate mofetil inhibits inosine monophosphate dehydrogenase (IMPDH), selectively suppressing proliferation of T and B lymphocytes.

Phase 3 pipeline (1)

Mycophenoate Mofetil · Hoffmann-La Roche · Inosine monophosphate dehydrogenase (IMPDH) inhibitor · Immunology
Mycophenolate mofetil inhibits inosine monophosphate dehydrogenase (IMPDH), selectively suppressing T and B lymphocyte proliferation to prevent immune rejection.